Want to join the conversation?
Vamil Divan of Credit Suisse asks about biosimilars, on Enbrel, what's the impact of biosimilars on 2016 results. $PFE President Geno Germano answers by saying that the first biosimilar for Etanercept has been approved in Europe. The overall expectation is that there will be some modest impact in 2016 and will have a strong business in Europe.
$PYPL jumps 6% in after hours on strong results. I am bullish on this stock.
$TSCO stock remained active in the after hours trading and rose more than 2% after the retailer posted better than expected 1Q17 results.
Instagram has reached 700 million monthly active users. Looks like it will hit 1 billion soon. That would make it $FB’s fourth billion-user platform.